|
|
Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Digoxin#Package and Label Display Panel]] |
| {{Digoxin}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| '''''For patient information, click <u>[[Digoxin (patient information)|here]]'''''</u>.
| |
| | |
| ==Labels and Packages==
| |
| 08-2013M
| |
| | |
| D46118410
| |
| | |
| Manufactured in Canada by
| |
| | |
| Sandoz Canada Inc. for
| |
| | |
| Sandoz Inc., Princeton, NJ 08540
| |
| | |
| '''500 mcg (0.5 mg) per 2 mL Carton'''
| |
| | |
| [[image:diginj11.jpg]]
| |
| | |
| NDC 0781-3059-95
| |
| | |
| Digoxin Injection, USP
| |
| | |
| 500 mcg (0.5 mg)/2 mL
| |
| | |
| [250 mcg (0.25 mg)/mL]
| |
| | |
| Sterile
| |
| | |
| For Intravenous or Intramuscular Injection
| |
| | |
| Dilution not required
| |
| | |
| Rx only
| |
| | |
| 5 x 2 mL Ampules
| |
| | |
| SANDOZ
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58f45aba-ff6f-43cc-bb88-be40a9f7beda
| |
| | |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |